Related Experiment Video
Updated: Jun 22, 2026
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.1K
OX40/OX40L as a Therapeutic Target in Atopic Dermatitis: A Scoping Review
Fernando Valenzuela1,2, Victor Meza1
1Department of Dermatology, Universidad de Los Andes, Santiago, Chile.
Biologics : Targets & Therapy
|May 7, 2025
Summary
Targeting the OX40-OX40L pathway shows promise for treating moderate-to-severe atopic dermatitis (AD). This approach may offer a new therapeutic option for patients with AD who have not responded to existing treatments.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin condition with complex causes.
- Current treatments for moderate-to-severe AD are insufficient for many patients.
- The OX40-OX40L signaling pathway is implicated in T cell-mediated inflammation in AD.
Purpose of the Study:
- To review the efficacy and safety of targeting the OX40-OX40L axis in moderate-to-severe AD.
- To summarize current research on OX40/OX40L inhibitors for AD treatment.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of data on therapeutic interventions targeting the OX40-OX40L pathway.
- Evaluation of treatment efficacy and safety profiles.
Main Results:
- Early research indicates potential efficacy of OX40-OX40L axis inhibition in AD.
- Therapies targeting this pathway have shown encouraging results in initial studies.
- Safety data suggests a favorable profile for OX40-OX40L inhibitors.
Conclusions:
- Inhibiting the OX40-OX40L signaling axis represents a promising therapeutic strategy for moderate-to-severe AD.
- Further research and clinical trials are warranted to confirm the long-term efficacy and safety.
- This approach may address unmet needs in AD management.
Related Concept Videos
01:23Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...